Huntsworth plc

HNT

GB00B0CRWK29

Advertising & Marketing

Delayed London S.E. Other stock markets 11:35:21 2020-04-30 am EDT			5-day change	1st Jan Change
107.5 ^GBX	-.--%		-.--%	+32.06%

2022	Huntsworth Limited acquired The Cirkle Partnership Limited.	CI
2020	Huntsworth Limited announced that it has received funding from Clayton, Dubilier & Rice, LLC	CI

Huntsworth Appoints Derek Mapp as Non-Executive Director and Chairman of its Board, Effective December 1, 2014

November 20, 2014 at 11:22 am EST

Huntsworth announced the appointment of Derek Mapp as a non-executive director and as chairman of its board with effect from December 1, 2014. He is currently non-executive chairman of Informa plc, non-executive chairman of Salmon Developments Limited and executive chairman of Imagesound Limited.

Latest news about Huntsworth plc

Huntsworth Limited acquired The Cirkle Partnership Limited.	22-04-06	CI
Huntsworth Limited announced that it has received funding from Clayton, Dubilier & Rice, LLC	20-12-30	CI
Huntsworth plc completed the acquisition of Nucleus Global Limited.	20-12-10	CI
Huntsworth plc entered into an agreement to acquire Nucleus Global Limited.	20-11-05	CI
Nicky Dulieu Step Down as Non-Executive Director of Huntsworth plc	20-05-01	CI
Huntsworth plc(LSE:HNT) dropped from FTSE All-Small Index	20-05-01	CI
Huntsworth plc(LSE:HNT) dropped from FTSE All-Share Index	20-05-01	CI
Clayton, Dubilier & Rice Fund X, L.P., Clayton, Dubilier & Rice Fund X-A, L.P., CD&R Advisor Fund X, L.P., funds managed by Clayton, Dubilier & Rice, LLC completed the acquisition of Huntsworth plc from Aberforth Partners LLP, Kabouter Management L.L.C., Kames Capital plc, Merian Global Investors (UK) Limited, Hargreave Hale Limited and others.	20-04-30	CI
Huntsworth plc Proposes Final Dividend, Payable on September 18, 2020	20-04-09	CI
Huntsworth : U.S. buyout firm CD&R to buy UK's Huntsworth for £400 million in pharma bet	20-03-03	RE
Huntsworth plc Propose Final Dividend for the Year Ended 31 December 2019, Payable on 6 July 2020	20-03-03	CI
Huntsworth plc Reports Earnings Results for the Full Year Ended December 31, 2019	20-03-03	CI
Clayton, Dubilier & Rice Fund X, L.P., Clayton, Dubilier & Rice Fund X-A, L.P., CD&R Advisor Fund X, L.P. funds managed by Clayton, Dubilier & Rice, LLC reached an agreement to acquire Huntsworth plc from Aberforth Partners LLP, Kabouter Management L.L.C., Kames Capital plc, Merian Global Investors (UK) Limited, Hargreave Hale Limited and others for approximately £400 million.	20-03-02	CI
Huntsworth plc Provides Revenue Guidance for the Year Ending December 31, 2019	19-12-17	CI
A selection of British stocks to play the Brexit game	19-10-16
Huntsworth plc Announces Board Changes	19-10-01	CI
Loretta Ahmed, Chief Executive Officer of Grayling Communications Limited acquired Grayling Communications Limited from Huntsworth plc.	19-09-11	CI
Huntsworth plc Announces Dividend for the First Half of 2019, Payable on November 6, 2019; Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2019	19-07-23	CI
Huntsworth PLC Appoints Helen Apostolidis as Chief Talent Officer	19-07-17	CI
Huntsworth plc acquired 70% stake in Creativ Ceutical S.À R.L. from Avicenne Invest S.A.	19-05-20	CI
Huntsworth plc acquired an 85% stake in Kyne Communications LLC and Kyne Communications Limited from David Kyne, his wife Jacqueline Kyne, and their associates for $17.4 million.	19-05-20	CI
Transcript : Huntsworth plc - Analyst/Investor Day	19-05-09
Huntsworth plc Announces Directorate Changes	19-03-06	CI
Huntsworth plc Proposes Final Dividend, Payable on July 4, 2019	19-03-05	CI
Huntsworth plc Reports Audited Preliminary Consolidated Earnings Results for the Year Ended December 31, 2018; Provides Earnings Guidance for the Fiscal Year 2019	19-03-05	CI

Chart Huntsworth plc

Duration

Period

More charts

Company Profile

Huntsworth Limited is a United Kingdom-based intermediate holding company. The Company is engaged in healthcare and communication activities. The Company, through its subsidiaries, is focused on health that provides marketing and medical communications services to healthcare clients, which are primarily large and mid-size pharmaceuticals and biotechnology companies. It also provides a range of communications and advisory services, including strategic communications, public affairs, investor relations and consumer marketing. The Companyâs financial instruments comprise bank loans, bank overdrafts, loan notes, and cash and short-term deposits. The Companyâs geographical areas include the United Kingdom, Europe, the United States and the rest of the world. The Companyâs subsidiaries operate in approximately 28 in the United Kingdom and Europe.

Sector

Advertising & Marketing

More about the company

Sector Other Advertising & Marketing

	1st Jan change	Capi.
HUNTSWORTH PLC	+32.06%	508M
PUBLICIS GROUPE SA	+25.83%	29.07B
OMNICOM GROUP., INC.	+11.72%	18.93B
FOCUS MEDIA INFORMATION TECHNOLOGY CO., LTD.	+6.80%	13.5B
THE INTERPUBLIC GROUP OF COMPANIES, INC.	-3.09%	11.94B
WPP PLC	+12.44%	11.62B
JCDECAUX SE	+18.35%	4.87B
AUTOHOME INC.	+5.27%	3.58B
CYBERAGENT, INC.	+16.43%	3.51B
PEOPLE.CN CO., LTD	-18.16%	3.51B

Other Advertising & Marketing

Huntsworth plc

Equities

HNT

GB00B0CRWK29

Advertising & Marketing

Huntsworth Appoints Derek Mapp as Non-Executive Director and Chairman of its Board, Effective December 1, 2014

Latest news about Huntsworth plc

Chart Huntsworth plc

Company Profile

Sector Other Advertising & Marketing